Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients
Autor: | Miguel Rodríguez-Fernández, Ignacio Santos, Miguel Ángel López-Ruz, Juan A. Pineda, Joseba Portu, Mohamed Omar, Marta Montero, Francisco Rodríguez-Arrondo, Marcial Delgado-Fernández, Koldo Aguirrebengoa, María A. García, Miguel García-Deltoro, Juan Macías, Antonio Rivero-Juárez, Francisco Jesús Vera-Méndez, Esperanza Merino, María José Galindo, Carlos Galera, Blanca Figueruela, Marina Villalobos, Nicolás Merchante, María J. Ríos-Villegas, Boris Revollo, Carlos Mínguez, Sofía Ibarra, Francisco Téllez |
---|---|
Přispěvatelé: | Junta de Andalucía, European Commission, Instituto de Salud Carlos III |
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
0301 basic medicine hepatitis C virus medicine.medical_specialty Carcinoma Hepatocellular Cirrhosis liver cirrhosis Immunology HIV Infections Sensitivity and Specificity 03 medical and health sciences 0302 clinical medicine Internal medicine Humans Immunology and Allergy Medicine Hiv infected patients 030212 general & internal medicine Stage (cooking) Aged Retrospective Studies Ultrasonography business.industry Liver Neoplasms Ultrasound HIV Hepatitis C hepatocellular carcinoma Middle Aged medicine.disease digestive system diseases 030104 developmental biology Infectious Diseases Spain Hepatocellular carcinoma Epidemiological Monitoring Cohort abdominal ultrasound surveillance Female business Viral load |
Zdroj: | Aids r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia instname AIDS r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol Digital.CSIC. Repositorio Institucional del CSIC r-FISABIO. Repositorio Institucional de Producción Científica |
ISSN: | 0269-9370 |
Popis: | On behalf of the GEHEP-002 Study Group. [Objective]: To assess the performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma (HCC) in HIV-infected patients. [Methods]: The GEHEP-002 cohort recruits HCC cases diagnosed in HIV-infected patients from 32 centers across Spain. The proportion of ‘ultrasound lack of detection’, defined as HCC diagnosed within the first 3 months after a normal surveillance ultrasound, and the proportion of ‘surveillance failure’, defined as cases in which surveillance failed to detect HCC at early stage, were assessed. To assess the impact of HIV, a control population of 104 HCC cases diagnosed in hepatitis C virus-monoinfected patients during the study period was used. [Results]: A total of 186 (54%) out of 346 HCC cases in HIV-infected patients were diagnosed within an ultrasound surveillance program. Ultrasound lack of detection occurred in 16 (8.6%) of them. Ultrasound surveillance failure occurred in 107 (57%) out of 186 cases diagnosed by screening, whereas this occurred in 18 (29%) out of 62 diagnosed in the control group (P < 0.0001). HCC cases after ultrasound surveillance failure showed a lower frequency of undetectable HIV viral load at diagnosis. The probability of 1-year and 2-year survival after HCC diagnosis among those diagnosed by screening was 56 and 45% in HIV-infected patients, whereas it was 79 and 64% in HIV-negative patients (P = 0.038). [Conclusion]: The performance of ultrasound surveillance of HCC in HIV-infected patients is very poor and worse than that shown outside HIV infection. A HCC surveillance policy based on ultrasound examinations every 6 months might be insufficient in HIV-infected patients with cirrhosis. The current study was supported by grants from the Consejería de Salud de la Junta de Andalucía (PI-0014/2014), the Servicio Andaluz de Salud (grant number SAS/111239) and the Fondo de Investigaciones Sanitarias ISCIII (grant number PI13/01621) and Project ‘PI16/01443’, funded by Instituto de Salud Carlos III, integrated in the national I+D+i 2013–2016 and co-funded by European Union (ERDF/ESF, ‘Investing in your future’). J.A.P. is the recipient of an intensification grant from the Instituto de Salud Carlos III (grant number Programa-I3SNS). Besides, this work has been partially funded by the Grupo para el Estudio de las Hepatitis Víricas (GEHEP) de la SEIMC (2017 grant to project GEHEP-002 and 2018 grant to project GEHEP-002), the SPANISH AIDS Research Network RD16/0025/0010 as part of the Plan Nacional R+D+I and cofinanced by ISCIII Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER). |
Databáze: | OpenAIRE |
Externí odkaz: |